The regulatory function of umbilical cord blood CD4+ CD25+ T cells stimulated with anti‐CD3/anti‐CD28 and exogenous interleukin (IL)‐2 or IL‐15
Authors:
- 8 October 2009
- journal article
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 20 (7) , 624-632
Abstract
The abundance of CD4(+) CD25(+) regulatory T cells in umbilical cord blood (UCB) might contribute to the decreased severity of graft-vs.-host disease (GVHD) for UCB transplantation. This study aims to characterize the phenotypes and suppressive function of UCB CD4(+) CD25(+) T cells under the influence of anti-CD3/anti-CD28 (CD3/CD28) and exogenous interleukin (IL)-2 or IL-15. Higher percentages of CD4(+) CD25(high) and FoxP3(+) cells were detected in UCB compared to their adult counterparts. IL-15 was as effective as IL-2 in enhancing the proliferation of CD3/CD28 stimulated UCB CD4(+) CD25(+) T cells. Phenotypically, IL-2/IL-15-stimulated UCB CD4(+) CD25(+) T cells expressed higher level of CTLA-4, GITR, membrane bound transforming growth factor-beta (mTGF-beta), and especially Foxp-3 than controls. IL-2/IL-15-stimulated UCB CD4(+) CD25(+) T cells also produced much higher IL-10 and TGF-beta than controls; while IL-2/IL-15-stimulated UCB CD4(+) CD25(-) T cells showed increased TGF-beta, but not IL-10 production. IL-2/IL-15-cultured UCB CD4(+) CD25(+) T cells showed comparable suppressor activity on allogeneic adult CD4(+) T-cell proliferation compared to controls, partly through a contact-dependent fashion. Taken together, IL-2/IL-15-stimulated UCB CD4(+) CD25(+) T cells show distinct regulatory T-cell phenotypic and functional features, and may be applied for the alleviation of GVHD severity following UCB transplantation.Keywords
This publication has 31 references indexed in Scilit:
- Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cellsJournal of Experimental Medicine, 2006
- Highly Efficient Expansion of Human CD4+CD25+ Regulatory T Cells for Cellular Immunotherapy in Patients with Graft-Versus-Host DiseaseJournal of Immunotherapy, 2006
- Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: Potential for adoptive T cell immunotherapyClinical Immunology, 2006
- Impaired Allogeneic Activation and T-helper 1 Differentiation of Human Cord Blood Naive CD4 T CellsTransplantation and Cellular Therapy, 2006
- Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: A comparative study of naïve and antigenic-specific cord blood Treg cellsExperimental Hematology, 2005
- Differential effect of IL-15 and IL-2 on survival of phytohemagglutinin-activated umbilical cord blood T cellsAmerican Journal of Hematology, 2005
- CD4+CD25+FOXP3+ regulatory T cells from human thymus and cord blood suppress antigen‐specific T cell responsesImmunology, 2005
- Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cellsBlood, 2004
- Distinctive response of naïve lymphocytes from cord blood to primary activation via TCRJournal of Leukocyte Biology, 2003
- Regulatory T cells in transplantation toleranceNature Reviews Immunology, 2003